Kann PH - Search Results

1

Increased arterial augmentation and augmentation index as surrogate parameters for arteriosclerosis in subjects with diabetes mellitus and nondiabetic subjects with cardiovascular disease.

Wilhelm B, Klein J, Friedrich C, Forst S, Pfützner A, Kann PH, Weber MM, Forst T. Wilhelm B, et al. Among authors: kann ph. J Diabetes Sci Technol. 2007 Mar;1(2):260-3. doi: 10.1177/193229680700100217. J Diabetes Sci Technol. 2007. PMID: 19888415 Free PMC article.

2

Reliability of lightguide spectrophotometry (O2C) for the investigation of skin tissue microvascular blood flow and tissue oxygen supply in diabetic and nondiabetic subjects.

Forst T, Hohberg C, Tarakci E, Forst S, Kann P, Pfützner A. Forst T, et al. J Diabetes Sci Technol. 2008 Nov;2(6):1151-6. doi: 10.1177/193229680800200625. J Diabetes Sci Technol. 2008. PMID: 19885305 Free PMC article.

3

Endothelial function and arterial stiffness in uncomplicated type 1 diabetes and healthy controls and the impact of insulin on these parameters during an euglycemic clamp.

Wilhelm B, Weber MM, Kreisselmeier HP, Kugler M, Ries C, Pfützner A, Kann PH, Forst T. Wilhelm B, et al. Among authors: kann ph. J Diabetes Sci Technol. 2007 Jul;1(4):582-9. doi: 10.1177/193229680700100417. J Diabetes Sci Technol. 2007. PMID: 19885122 Free PMC article.

4

IRIS II Study: Sensitivity and specificity of intact proinsulin, adiponectin, and the proinsulin/adiponectin ratio as markers for insulin resistance.

Langenfeld MR, Forst T, Standl E, Strotmann HJ, Lübben G, Pahler S, Kann P, Pfützner A; IRIS II study. Langenfeld MR, et al. Diabetes Technol Ther. 2004 Dec;6(6):836-43. doi: 10.1089/dia.2004.6.836. Diabetes Technol Ther. 2004. PMID: 15684637

5

Influence of glucose control and improvement of insulin resistance on microvascular blood flow and endothelial function in patients with diabetes mellitus type 2.

Forst T, Lübben G, Hohberg C, Kann P, Sachara C, Gottschall V, Friedrich C, Rosskopf R, Pfützner A. Forst T, et al. Microcirculation. 2005 Oct-Nov;12(7):543-50. doi: 10.1080/10739680500253402. Microcirculation. 2005. PMID: 16207627 Clinical Trial.

6

Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance.

Pfützner A, Kann PH, Pfützner AH, Kunt T, Larbig M, Weber MM, Forst T. Pfützner A, et al. Among authors: kann ph. Clin Lab. 2004;50(9-10):567-73. Clin Lab. 2004. PMID: 15481632 Review.

7

The switch from sulfonylurea to preprandial short- acting insulin analog substitution has an immediate and comprehensive beta-cell protective effect in patients with type 2 diabetes mellitus.

Pfützner A, Lorra B, Abdollahnia MR, Kann PH, Mathieu D, Pehnert C, Oligschleger C, Kaiser M, Forst T. Pfützner A, et al. Among authors: kann ph. Diabetes Technol Ther. 2006 Jun;8(3):375-84. doi: 10.1089/dia.2006.8.375. Diabetes Technol Ther. 2006. PMID: 16800759 Clinical Trial.

8

Elevated Intact Proinsulin Levels During an Oral Glucose Challenge Indicate Progressive ß-Cell Dysfunction and May Be Predictive for Development of Type 2 Diabetes.

Pfützner A, Hermanns I, Ramljak S, Demircik F, Pfützner AH, Kann PH, Weber MM. Pfützner A, et al. Among authors: kann ph. J Diabetes Sci Technol. 2015 Sep 29;9(6):1307-12. doi: 10.1177/1932296815607862. J Diabetes Sci Technol. 2015. PMID: 26420624 Free PMC article.

9

Clinical and Laboratory Evaluation of a New Specific Point-of-Care Test for Intact Proinsulin.

Pfützner A, Pfützner AH, Kann PH, Burgard G. Pfützner A, et al. Among authors: kann ph. J Diabetes Sci Technol. 2017 Mar;11(2):278-283. doi: 10.1177/1932296816663745. Epub 2016 Sep 25. J Diabetes Sci Technol. 2017. PMID: 27559030 Free PMC article.

10

Changes in insulin resistance and cardiovascular risk induced by PPARgamma activation have no impact on RBP4 plasma concentrations in nondiabetic patients.

Pfützner A, Schöndorf T, Hanefeld M, Lübben G, Kann PH, Karagiannis E, Wilhelm B, Forst T. Pfützner A, et al. Among authors: kann ph. Horm Metab Res. 2009 Mar;41(3):202-6. doi: 10.1055/s-0028-1104592. Epub 2009 Feb 17. Horm Metab Res. 2009. PMID: 19224430 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters